Fibrinogen Binding Is Independent of an Increase in Intracellular Calcium Concentration in Thrombin Degranulated Platelets

Summary

In a suspension of thrombin degranulated platelets (TDP), ADP and epinephrine can induce platelet aggregation, whereas the synthetic agonist of the thromboxane/endoperoxide receptor U46619 causes only shape change. However, U46619 can enhance platelet aggregation induced by ADP and epinephrine. In this paper, we have measured fibrinogen binding in relation to phospholipase C(PLC) activation and calcium mobilization in TDP activated by ADP, epinephrine and U46619.

ADP caused fibrinogen binding in TDP but neither activated PLC nor caused a calcium mobilization. The requirement for ADP in inducing exposure of fibrinogen binding sites was not absolute since the combination of epinephrine and U46619 produced an increase in fibrinogen binding. U46619 caused significant PLC activation and cytosolic calcium release but not fibrinogen binding. These results suggest that in TDP the exposure of fibrinogen binding sites, after agonist activation, is independent of both PLC activation and calcium mobilization.

• References

• 1 Pytela R, Pierschbacher MD, Ginsberg MH, Plow EF, Ruoslahti E. Platelet membrane glycoprotein IIb/IIIa: member of a family of Arg-Gly-Asp-specific adhesion receptors. Sci 1986; 231: 1559-1562
• 2 Gartner TK, Bennet JS. The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets. J Biol Chem 1985; 260: 11891-11894
• 3 Ginsberg MH, Loftus JC, Plow EF. Cytoadhesins, integrins, and platelets. Thromb Haemost 1988; 59: 1-6
• 4 Shattil SJ. Regulation of platelet anchorage and signaling by integrin αIIb-β3. Thromb Haemost 1993; 70: 224-228
• 5 Morinelli TA, Niewiarowski S, Kornecki E, Figures WR, Wachtfogel Y, Colman RW. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues. Blood 1983; 61: 41-49
• 6 Pulcinelli FM, Daniel JL, Riondino S, Gazzaniga PP, Russo PP, Salganicoff L. A method to prepare thrombin degranulated platelets. Platelets 1993; 4: 212-218
• 7 Huang EM, Detwiler TC. Stimulus-response coupling mechanisms. In: Biochemistry of platelets. Phillips DR, Shuman MA. eds. New York: Academic Press; 1986. pp 1-68
• 8 Ashby B, Daniel JL, Smith JB. Mechanisms of platelet activation and inhibition. In: Hematology/Oncology Clinics of North America. Platelets in health and disease Colman RW, Rao AK. eds. Philadelphia: Saunders Company; 1990. pp 1-26
• 9 Aster RH, Jandel JH. Platelet sequestration in man. I. Methods J Clin Invest 1964; 43: 834-855
• 10 Marguerie GA, Plow EF, Edgington TS. Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979; 254: 5357-5363
• 11 Grynkiewicz G, Poenie M, Tsien RY. A new generation of Ca²⁺ indicators with greatly improved fluorescence properties. J Biol Chem 1985; 260: 3440-3445
• 12 Pulcinelli FM, Gazzaniga PP, Salganicoff L. Use of Zn-pyrophosphatase in the high-performance liquid chromatographic analysis of cell extracts containing ³²P-labelled inositol phosphates. J Chromatogr 1992; 575: 51-55
• 13 Daniel JL, Dangelmaier CA, Smith JB. Formation and metabolism of inositol 1, 4, 5-triphosphate in human platelets. Biochem J 1987; 246: 109-114
• 14 Haslam RJ. Role of the adenosine diphosphate in the aggregation of human blood platelets by thrombin. Nature 1964; 202: 765
• 15 Ingerman CM, Smith JB, Shapiro S, Sedar A, Silver MJ. Hereditary abnormality of platelet aggregation attributable to nucleotide storage pool deficiency. Blood 1978; 52: 332-344
• 16 MacFarlane DE, Mills DC B. The effect of ATP: evidence against the central role of released ADP in primary aggregation. Blood 1975; 46: 309-320
• 17 Shattil SJ, Budzynski A, Scrutton MC. Epinephrine induces platelet fibrinogen receptor expression, fibrinogen binding, and aggregation in whole blood in the absence of other excitatory agonists. Blood 1989; 73: 150-158
• 18 Daniel JL, Dangelmaier CA, Selak M, Smith JB. ADP stimulates IP3 formation in human platelets. FEBS Lett 1986; 206: 299-303
• 19 Vickers JD, Kinlough-Rathbone RL, Packham MA, Mustard JF. Inositol phospholipid metabolism in human platelets stimulated by ADP. Eur J Biochem 1990; 193: 521-528
• 20 Ginsberg MH, Xiaoping D, O'Toole TE, Loftus JC, Plow EF. Platelet- integrins. Thromb Haemost 1993; 70: 87-93
• 21 Parise LV, Criss AB, Nannizzi L, Wardell MR. Glycoprotein IIIa is phosphorylated in intact human platelets. Blood 1990; 75: 2363-2368
• 22 Hillery CA, Smyth SS, Parise LV. Phosphorylation of human platelet glycoprotein IIIa (GPIIIa). Dissociation from fibrinogen binding receptor activation and phosphorylation of GPIIIa in vitro J Biol Chem 1991; 266: 14663-14669
• 23 Shattil SJ, Cunningham M, Wiedmer T, Zhao J, Sims PJ, Brass LF. Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the pore-forming complement proteins C5b-9. J Biol Chem 1992; 267: 18424-18431
• 24 Morii N, Teru-uchi T, Tominaga T, Kumagai N, Kozaki S, Ushikubi F, Narumiya S. A rho gene product in human blood platelets. II. Effect of the ADP-ribosylation by botulinum C3 ADP-ribosyltransferase on platelet aggregation J Biol Chem 1992; 267: 20921-20926